Stock Events

Stock Events

Search...

Ultragenyx Pharmaceutical (RARE) Q1 2026 Earnings

12FebConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-1.81

-1.57

-1.33

-1.09

Details

Expected EPS

-1.092584

Actual EPS

-1.29

Surprise EPS

-0.2

Surprise Percent

+18.07%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.29 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.